3rd Circ. Backs $1M FBAR Penalty Against Ex-Pharma CEO

By David Hansen · July 22, 2022, 5:02 PM EDT

A former pharmaceutical CEO faces almost $1 million in penalties for failing to report his Swiss bank accounts after a Third Circuit panel Friday affirmed a lower court ruling that his...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login